Rachel Kuperman

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

David Neal Franz, Steven Sparagana, E. Martina Bebin et al. · The Lancet · 2012 · 771 citations

Tuberous Sclerosis Complex, Neuro-oncology, Placebo-controlled Phase 3 +7

Ultra-rare genetic variation in common epilepsies: a case-control sequencing study

Andrew S. Allen, Susannah T. Bellows, Samuel F. Berkovic et al. · The Lancet Neurology · 2017 · 232 citations · Full text

Allelic Variant, Ultra-rare Genetic Variation, Medicine +8

Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study

David Neal Franz, Steven Sparagana, E. Martina Bebin et al. · PLoS ONE · 2016 · 203 citations · Full text

Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial

Cynthia Sharpe, Gail Reiner, Suzanne L. Davis et al. · PEDIATRICS · 2020 · 196 citations · Full text

Dynamic Changes in Phase-Amplitude Coupling Facilitate Spatial Attention Control in Fronto-Parietal Cortex

Sara M. Szczepanski, Nathan E. Crone, Rachel Kuperman et al. · PLoS Biology · 2014 · 187 citations · Full text

Neuropsychology, Fronto-parietal Cortex, Neurolinguistics +21